Mucosal immunity: induction, dissemination, and effector functions.
about
Secretory IgA: Designed for Anti-Microbial DefenseStress modulates intestinal secretory immunoglobulin A.Human plasma-derived polymeric IgA and IgM antibodies associate with secretory component to yield biologically active secretory-like antibodiesSecretory IgA's complex roles in immunity and mucosal homeostasis in the gutThe Mucosal Immune System and Its Regulation by AutophagyImmunopathology of inflammatory bowel diseaseThe microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrheaM-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensisVaccines against enteric infections for the developing worldDistribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in miceThe mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine.Primary transcriptomes of Mycobacterium avium subsp. paratuberculosis reveal proprietary pathways in tissue and macrophages.Mannose-containing oligosaccharides of non-specific human secretory immunoglobulin A mediate inhibition of Vibrio cholerae biofilm formation.Primary B-cell deficiencies reveal a link between human IL-17-producing CD4 T-cell homeostasis and B-cell differentiation.Effect of vitamin e supplementation on intestinal barrier function in rats exposed to high altitude hypoxia environmentOral intake of Lactobacillus pentosus strain b240 accelerates salivary immunoglobulin A secretion in the elderly: A randomized, placebo-controlled, double-blind trialRobust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody.Putting J chain back on the map: how might its expression define plasma cell development?Enhancement of the immunogenicity and protective efficacy of a mucosal influenza subunit vaccine by the saponin adjuvant GPI-0100.B cell response to herpesvirus infection of the olfactory neuroepithelium.Passive administration of purified secretory IgA from human colostrum induces protection against Mycobacterium tuberculosis in a murine model of progressive pulmonary infection.The mucosal adjuvant cholera toxin B instructs non-mucosal dendritic cells to promote IgA production via retinoic acid and TGF-β.Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamicsDiseases of the nose and paranasal sinuses in child.Small intestine mucosal immune system response to injury and the impact of parenteral nutrition.Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategiesIntranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis.Impaired Cellular Immunity in the Murine Neural Crest Conditional Deletion of Endothelin Receptor-B Model of Hirschsprung's DiseaseTFH cells accumulate in mucosal tissues of humanized-DRAG mice and are highly permissive to HIV-1Age, microbiota, and T cells shape diverse individual IgA repertoires in the intestineMethylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually.Gut-lung axis: The microbial contributions and clinical implications.Mucosal immunoglobulins and B cells of teleost fish.Combined Oral and Intravenous Immunization Stimulates Strong IgA Responses in Both Systemic and Mucosal Compartments.IgT, a primitive immunoglobulin class specialized in mucosal immunity.Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study.Mucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination.Secretory immunity with special reference to the oral cavity.Gut Lymphocyte Phenotype Changes After Parenteral Nutrition and Neuropeptide Administration
P2860
Q21131208-E3225B67-ACC3-4A06-9B7B-18B5AFD84D7CQ21558386-B86018D8-9DC9-40E4-8F00-E7C521E2FB76Q24306450-0689EA51-6C72-4D98-B69C-8C59E2256FD5Q24620817-4F41D33B-1F0F-492F-8AA8-6E9D456A255FQ26742170-3DD6BD81-2BAD-466D-9BA3-CB25DF2480F0Q27027636-FCDD5F93-CD00-4CC6-8A64-40575651EF07Q27313421-705E6297-6D98-4E82-8474-3A5F46E461CDQ27314549-7B4BD831-251E-45DA-8E55-85186594DBA2Q28080866-8B620837-3055-4B41-8B4A-3F7DB6331AD0Q28477998-FDE1E88A-1B15-48ED-8B88-B5FC59937E10Q30404699-075E22A5-0A1F-4DEE-9C9F-3E2BDDD892F5Q33715815-67394EE7-EF13-4FFA-9AFC-0DD2B6086FAAQ33828704-15A29A80-6F29-4F42-A2A0-71E814AFFB5DQ33986006-00162849-7F6A-44E4-A742-68EEA5823BF8Q34097890-BCE13D8F-28A1-4CE5-BB85-3FF753C94A52Q34114375-89ABB928-F78C-41F2-85CC-A0CA5669E45AQ34175747-96FCE55B-780C-4B6C-A427-72538FAEFB27Q34283442-E7510385-01F7-4DBF-8435-C144D8BFD850Q34347803-9D7F8174-A464-471A-9C1D-9A022841BC39Q34533085-5FA305C1-E888-4D85-972D-D4BD7CBA44D1Q34594943-830A2ED2-5902-4B66-AA47-9A5F089230AAQ34607559-B13BC4C4-78ED-4F4A-A747-CF534904377AQ34635533-4375F805-C82C-473B-A7AC-0D858ED4EAE8Q34669980-30416CA6-2DCB-4183-830C-1D8A6670386BQ34751071-DFD98F04-DC47-470C-BDD1-D260C37E487DQ34792159-4A422C53-CDCA-4D2F-819C-6DE32D01C85FQ34920723-C85BAF05-21CE-4FBC-9B03-F8C2B8D92AABQ35080048-31E5CA1C-7C95-4368-8229-97B3A8409197Q35660153-49109A71-342A-4396-B450-02D2DF09AF6FQ35673120-DD7C28EA-1E2B-4190-862F-325C083BA960Q35760860-95C4F3C9-7016-46B4-9207-067A5A2B579EQ36173746-644371CE-2676-4F1E-9A11-49B39515B942Q36174406-D1A69058-4750-45C5-872D-CBAD09CA1C86Q36190929-E5F3825E-04F8-4DFC-A91C-65F9B85E27CAQ36218660-515C7764-BAE5-43E5-BAAC-E7EC638DB4FBQ36284405-2F79747B-7B9F-4C09-98EA-8C41DF2D60E4Q36346774-CFB216FD-25B7-4DF4-8A89-D5A6836ED993Q36431001-232FE36D-9E36-4CA8-891D-94ED00B91B11Q36678122-D3CFB427-DB0B-459B-AEFB-CF9771326A34Q36833467-42A5A17D-F18A-484D-B093-E1D37E6B1D40
P2860
Mucosal immunity: induction, dissemination, and effector functions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mucosal immunity: induction, dissemination, and effector functions.
@en
Mucosal immunity: induction, dissemination, and effector functions.
@nl
type
label
Mucosal immunity: induction, dissemination, and effector functions.
@en
Mucosal immunity: induction, dissemination, and effector functions.
@nl
prefLabel
Mucosal immunity: induction, dissemination, and effector functions.
@en
Mucosal immunity: induction, dissemination, and effector functions.
@nl
P1476
Mucosal immunity: induction, dissemination, and effector functions.
@en
P2093
P Brandtzaeg
P2860
P304
P356
10.1111/J.1365-3083.2009.02319.X
P577
2009-12-01T00:00:00Z